← Back to SANA

Sana Biotechnology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
−$64−$47−$42−$94−$49−$60−$50−$107
−$0.22−$0.17−$0.16−$0.39−$0.21−$0.25−$0.21−$0.49
296277260238238235234217

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.